Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Samsung Electronics (005930) – Corporate Value-up Plan (Voluntary Disclosure) / 2026-03-19 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Clarification on Rumors or Reports (Unconfirmed) / 2024-06-20 Disclosures
  • [Disclosure] Jusung Engineering(036930) – Investor Relations (IR) Presentation / 2024-05-23 Semiconductors
  • [Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in Europe (Part 1 & 2) / 2024-08-23 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Clarification of Rumors or Reports / 2026-04-09 Disclosures
  • [Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2025-12-04 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Industry Slowdown · HBM Demand Slowdown · Intensifying Competition / 2025-07-25 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – Outlook on Business Performance (Consolidated Financial Results) / 2024-01-24 Disclosures

[Disclosure] Wonik IPS (240810) – Change in Sales or Profit/Loss Structure by More Than 30% (15% for Large Companies) / 2024-02-21

Posted on February 21, 2024August 3, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Wonik IPS reported FY2023 consolidated revenue of KRW 690.3B (-31.75% YoY) and turned to an operating loss of KRW 18.1B and net loss due to reduced facility investments by major customers.

📊 [Key Disclosure Contents & Summary Metrics]

  • Financial Statement Type: Consolidated Financial Statements
  • Changes in Sales & Profitability (FY2023):
    • Revenue: KRW 690.3B (KRW 690,337,586,778)
      • -31.75% YoY (vs. Previous FY: KRW 1,011,484,981,702 / Change: -KRW 321,147,394,924)
    • Operating Profit: KRW -18.1B (KRW -18,074,991,250)
      • Turned to Deficit YoY (vs. Previous FY: KRW 97,554,876,588 / Change: -KRW 115,629,867,838)
    • Profit Before Income Tax: KRW -20.9B (KRW -20,856,769,187)
      • Turned to Deficit YoY (vs. Previous FY: KRW 117,338,639,677 / Change: -KRW 138,195,408,864)
    • Net Profit: KRW -13.5B (KRW -13,507,700,947)
      • Turned to Deficit YoY (vs. Previous FY: KRW 89,438,212,718 / Change: -KRW 102,945,913,665)
  • Financial Position (FY2023):
    • Total Assets: KRW 1,084,862,841,788 (approx. KRW 1.08T)
    • Total Liabilities: KRW 218,160,246,280 (approx. KRW 218.2B)
    • Total Equity: KRW 866,702,595,508 (approx. KRW 866.7B)
    • Capital Stock: KRW 24,541,950,500 (approx. KRW 24.5B)
  • Primary Reason for Changes: Decrease in sales and profits resulting from reduced facility investments by key customers
  • Board Resolution Date: February 21, 2024 (3 Outside Directors Present, 0 Absent)
  • Other Investment Considerations:
    • Figures are prepared under K-IFRS on a consolidated basis prior to external audit completion.
    • Figures remain subject to change during the external audit and annual general meeting approval processes.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of External Audit Report and Annual Shareholders’ Meeting Approval

This disclosure provides preliminary notice of significant changes in annual sales and financial performance prior to the completion of the external audit. Checking whether the reported earnings figures align with the final audited numbers is recommended. Detailed audited figures can be checked through the upcoming ‘Submission of Audit Report’ disclosure, the ‘Annual Report’, and the ‘Results of General Shareholders’ Meeting’ disclosure.

📢 Disclaimer & Source Notice

Source: This content is structured and rewritten based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] Wonik IPS (240810) – Decision on Calling of General Shareholders’ Meeting / 2024-02-21
Next Post: [Disclosure] Wonik IPS (240810) – Consolidated Financial Results (Provisional) / 2024-02-21

Related Posts

  • [Disclosure] Hanwha Aerospace (012450) – Organization of Investor Relations Event / 2026-01-20 Disclosures
  • [Disclosure] SK Square (402340) – Correction of Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2026-03-03 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Acquisition of Shares and Equity Securities of Other Corporations / 2025-12-23 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Holding / 2024-03-12 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Conclusion of Single Sales/Supply Contract / 2025-12-11 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Results of Annual General Meeting of Shareholders / 2026-03-18 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Provisional Sales Results / 2026-04-01 Disclosures
  • [Disclosure] Hana Micron (067310) – Ex-Rights (Bonus Issue) / 2024-08-07 Semiconductors
  • [Disclosure] Jeju Semiconductor(080220) – (Correction) Resolution on Convening of Extraordinary General Meeting of Shareholders / 2026-05-14 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Notice of Dividend Record Date Change / 2024-12-13 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Clarification on Rumors or Reports (Unconfirmed) / 2024-06-20 Disclosures
  • [Disclosure] Celltrion (068270) – Final Marketing Authorization Granted by European Commission (EC) for Omlyclo (CT-P39, Xolair Biosimilar) / 2024-05-24 Disclosures
  • [Disclosure] Jusung Engineering (036930) – Decision on Conclusion of Trust Contract for Acquisition of Treasury Shares / 2024-10-29 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | AI & ADAS Mix · Margin Expansion · Valuation Re-rating / 2025-01-31 RESEARCH

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme